Autopsy report · NCT04575818

A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Development of compound has been stopped”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 7 months before it stopped.
32 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Lakefront Biotherapeutics NV
Sponsor type: Industry
Conditions: Healthy
Interventions: GLPG4059 oral suspension; Placebo; GLPG4059 tablet
Participants: 32
Sites: 1
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.